Home » Glenmark Gets USFDA Nod to Market Cancer Drugs
Glenmark Gets USFDA Nod to Market Cancer Drugs
Glenmark Pharmaceuticals Ltd on Friday said it has received the United States Food and Drug Administration (USFDA) approval to market two of its products used in treatment of cancer.
Economic Times
Upcoming Events
-
07May
-
14May
-
30May